USPTO serial 78723377
PHARMAGUILD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GAST, PAUL
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PHARMAGUILD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical agents for chelating and sequestering | ACTIVE | — |
| 003 | Hair and skin emollients | ACTIVE | — |
| 005 | Medicinal preparations, namely analgesics, muscle relaxants, antipyretic analgesics, pharmaceutical antitussive-cold preparations, vitamins, vitamin and mineral supplements, hematinics, anti-anginals, antihypertensives, antibiotics, adrenocorticals, injectable pharmaceuticals for treatment of anaphylactic reactions, coronary vasodilators, anthelmintics, anti-arthritics, corticosteroids, antirheumatics, sulfonamide preparations, anticoagulants, antidepressants, antihistaminics, antiserotonins, diuretics, anti-edemics, hypotensives, anti-infectives, anti-inflammatories, antineoplastics, antiparkinsonism preparations, antipruritics, allergy relief medication, skeletal muscle relaxants, anxiolytics, evacuants, cathartics, enema preparations, laxatives, cardiovascular pharmaceuticals, cortisones, decongestants, expectorants, ophthalmic preparations, glaucoma agents, dexamethasone, androgenics, enuretics, medicated skin emollients, estrogenics, german measles prophylactics, pharmaceutical preparation for the treatment of gout, uricosurics, hematopoietics, namely for use in stem cell research, antithyroid preparations, hyperthyroidism preparations, lactation inhibitors, measles prophylactics, mumps prophylactics, nephritis preparations, urinary antiseptics, neurosis and psychoneurosis preparations, antipsychotics, osteomyelitics, otitis preparations, oxyuriasis preparations, parasiticides for medical use, parasympathomimetics, pharyngitis preparations, vaccines against pneumococcal infections, prednisone preparations, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, salicylates for use to relieve pain and reduce fever, uretheritics, namely preparations to treat urethritis an inflammation of the urethra, vaccines, penicillamine chelating preparations, beta-adrenergic blockers, timolol maleate, namely a non-selective beta-adrenergic receptor blocker used to treat high blood pressure, prevent heart attacks, and occasionally prevent migraine headaches, antivenins, agricultural and animal health products, namely, fungicides; coccidiostats; antibiotics; anthelmintics; vitamin preparations; dermatological preparations, chemical compounds labeled with stable isotopes, namely, radio-isotope markers for therapeutic or diagnostic use | ACTIVE | — |
| 009 | Motion picture films about the pharmaceutical, medical, chemical and veterinarian fields | ACTIVE | — |
| 016 | Prints and publications, namely, namely, books, booklets, pamphlets, periodicals, manuals, and house organs, all relating to the pharmaceutical, medical, chemical and veterinarian fields | ACTIVE | — |
| 041 | Providing seminars to professional groups in the pharmaceutical, medicinal, veterinarian and nursing fields | ACTIVE | — |
| 042 | Pharmaceutical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARMAGUILD TECHNOLOGIES INC.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named PHARMAGUILD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2015 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Jan 21, 2015 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Nov 3, 2008 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 3, 2008 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2008 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 1, 2008 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 1, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 1, 2007 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2007 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 8, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 5, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2005 | NWAP | NEW APPLICATION ENTERED | — |